At this time, the entity appears to be fairly valued. PACS Group owns a latest Real Value of USD38.1 per share. The recent price of the entity is USD36.87. Our model determines the value of PACS Group from evaluating the entity fundamentals such as operating margin of 0.07 %, and Return On Asset of 0.0357 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PACS's valuation include:
Price Book
6.5625
Enterprise Value
8.8 B
Enterprise Value Ebitda
25.8832
Price Sales
1.1091
Forward PE
17.5439
Fairly Valued
Today
36.87
Please note that PACS's price fluctuation is very steady at this time. Calculation of the real value of PACS Group is based on 3 months time horizon. Increasing PACS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PACS stock is determined by what a typical buyer is willing to pay for full or partial control of PACS Group. Since PACS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PACS Stock. However, PACS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 36.87
Real 38.1
Target 45.6
Hype 35.98
Naive 33.47
The intrinsic value of PACS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PACS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PACS Group helps investors to forecast how PACS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PACS more accurately as focusing exclusively on PACS's fundamentals will not take into account other important factors:
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PACS's intrinsic value based on its ongoing forecasts of PACS's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PACS's closest peers.
PACS Cash
135.91 Million
PACS Total Value Analysis
PACS Group is at this time forecasted to have valuation of 8.83 B with market capitalization of 5.87 B, debt of 3.2 B, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PACS fundamentals before making equity appraisal based on enterprise value of the company
About 72.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.17. PACS Group had not issued any dividends in recent years. Based on the key indicators related to PACS's liquidity, profitability, solvency, and operating efficiency, PACS Group is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PACS has an asset utilization ratio of 94.72 percent. This implies that the Company is making USD0.95 for each dollar of assets. An increasing asset utilization means that PACS Group is more efficient with each dollar of assets it utilizes for everyday operations.
Covid
Interest Hikes
PACS Profitability Analysis
Based on PACS's profitability indicators, PACS Group is yielding more profit at this time then in previous quarter. It has a moderate probability of reporting better profitability numbers in April. Profitability indicators assess PACS's ability to earn profits and add value for shareholders.
Net Income
First Reported
2010-12-31
Previous Quarter
191.5 M
Current Value
122.9 M
Quarterly Volatility
44.7 M
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
At this time, PACS's Pretax Profit Margin is comparatively stable compared to the past year. Operating Profit Margin is likely to gain to 0.07 in 2026, whereas Gross Profit is likely to drop slightly above 594.4 M in 2026.
For PACS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PACS Group to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PACS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PACS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PACS over time as well as its relative position and ranking within its peers.
PACS Earnings per Share Projection vs Actual
By analyzing PACS's earnings estimates, investors can diagnose different trends across PACS's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for PACS Group is based on EPS before non-recurring items and includes expenses related to employee stock options.
Covid
Interest Hikes
PACS is projected to generate 0.3998 in earnings per share on the 31st of March 2026. PACS earnings estimates show analyst consensus about projected PACS EPS (Earning Per Share). It derives the highest and the lowest estimates based on PACS's historical volatility. Many public companies, such as PACS, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.
PACS Ownership Allocation
PACS Group secures a total of 155.18 Million outstanding shares. PACS Group owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 71.93 % of PACS Group outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that around one million five hundred ninety-eight thousand three hundred twenty-eight invesors are currently shorting PACS expressing very little confidence in its future performance.
PACS Profitability Analysis
The company reported the previous year's revenue of 5.29 B. Net Income was 55.76 M with profit before overhead, payroll, taxes, and interest of 818.95 M.
About PACS Valuation
The stock valuation mechanism determines PACS's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of PACS Group based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of PACS. We calculate exposure to PACS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PACS's related companies.
Investing in growth stocks can be very risky. If the company such as PACS does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding
156.7 M
Quarterly Earnings Growth Y O Y
0.572
Forward Price Earnings
17.5439
PACS Current Valuation Indicators
PACS's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final PACS's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PACS, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PACS's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PACS's worth.
Additional Tools for PACS Stock Analysis
When running PACS's price analysis, check to measure PACS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS is operating at the current time. Most of PACS's value examination focuses on studying past and present price action to predict the probability of PACS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS's price. Additionally, you may evaluate how the addition of PACS to your portfolios can decrease your overall portfolio volatility.